Year: 2002
Type: article
Abstract: This article, prepared by the Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guidelines Panel, updates guidelines established a decade ago by the Infectious Disease Society of America for the use of antimicrobial agents to treat neutropenic patients with unexplained fever [1]. DefinitionsFever is defined as a single oral temperature of у38.3ЊC (101ЊF) or a temperature of у38.0ЊC (100.4ЊF) for у1 h.Neutropenia is defined as a neutrophil count of !500 cells/mm 3 , or a count of !1000 cells/mm 3 with a predicted decrease to !500 cells/mm 3 . Initial EvaluationDetermine whether the patient is at low risk for complications; determine whether vancomycin therapy is needed. Initial Antibiotic TherapyOral route.For low-risk adults only; use ciprofloxacin plus amoxicillin-clavulanate. Monotherapy with vancomycin not indicated.
Source: Clinical Infectious Diseases
DOI: 10.1086/339215
Institutions: St. Jude Children's Research Hospital, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, University of Manitoba, Centre Hospitalier Universitaire Vaudois, Princess Margaret Cancer Centre, Harvard University, Stanford Medicine, Stanford University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2166858780
